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Chronic Pseudomonas aeruginosa lung infection is the most severe complication in
CF patients. The infection is characterised by bioﬁlm surrounded by numerous poly-
morphonuclear leukocytes (PMNs) and anaerobic conditions in the endobronchial
mucus. The O2 depletion in CF sputum is mainly due to O2 consumption by the
activated PMNs for production of superoxide and nitric oxide. On the contrary,
O2 consumption by aerobic respiration is diminutive and nitrous oxide (N2O) is
produced, suggesting that the reported in situ growth rates of P. aeruginosa in
expectorated mucus (Yang et al., J Bacteriol. 2008; 190: 2767) may be obtained by
anaerobic respiration using denitriﬁcation. The growth rate of P. aeruginosa during
denitriﬁcation at physiological levels of nitrate (NO−3 ) is, however, not known.
Therefore we have estimated growth rates by measuring the optical density of anoxic
cultures of PAO1 in LB media supplemented with NO−3 .
Growth rates were signiﬁcantly increased at supplementation with 150 mM NO−3
and higher. Within the physiological range of NO−3 (<600mM NO
−
3 ) growth rates of
0.50–0.67 divisions h−1 were calculated. To conﬁrm engagement of denitriﬁcation
at physiological levels of NO−3 we showed that N2O release is increased by a nitrous
oxide reductase deﬁcient mutant even at 63mM NO−3 . The growth rates obtained by
denitriﬁcation in the present study were comparable to the observed in situ growth
rates in the majority of P. aeruginosa cells in CF sputum (Yang et al., J Bacteriol.
2008; 190: 2767).
Thus, we have substantiated that growth of P. aeruginosa may be supported by
denitriﬁcation in the anoxic parts of the infected endobronchial CF mucus.
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Chronic bacterial infections are a key feature of a variety of lung conditions
including lung infections in cystic ﬁbrosis patients. The opportunistic bacterium,
Pseudomonas aeruginosa, is extremely skilled at both colonising and persisting in
the airways of patients with lung damage leading to life-long infections. It has been
suggested that the upper airways (including the paranasal sinuses and nasopharynx)
play an important role as a silent reservoir of bacteria. Over time, P. aeruginosa can
adapt during chronic infections leading to persistence in the face of the immune
system and intense therapy regimes.
Methods: In this study, we describe a novel murine model of intranasal inoculation
that establishes an infection lasting at least 28 days. This model utilises a natural
inoculation route and enables the study of the role of the upper airways and the
adaptation and migration of the bacteria to the lower airways.
Results: Upregulation of gene expression relating to bioﬁlm formation and vir-
ulence was determined using qPCR. Adaptation was studied through the use of
next generation sequencing and phenotypic testing revealing both small nucleotide
polymorphism changes and changes in antibiotic resistance.
Discussion: These data support the hypothesis that P. aeruginosa persistence in the
airways and the suggestion that the upper respiratory tract is a key niche in the
establishment of infection.
Conclusion: This novel model provides a unique platform for studying evolutionary
dynamics and therapeutics.
We would like to acknowledge the Leverhulme Trust for funding.
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Objectives: Interactions between bacteria may affect their virulence. P aeruginosa
is commonly co-cultured with Streptococcus sp. or Prevotella sp. The aims of this
study were to determine (1) if the virulence of clinical isolates of P aeruginosa,
Prevotella sp. and Streptococcus sp. using the Galleria mellonella model and
(2) if co-culture of P. aeruginosa with Streptococcus sp. or Prevotella sp. increases
virulence.
Methods: P. aeruginosa, Streptococcus sp. and Prevotella sp. (104−108 to CFU/ml)
were used to infect G. mellonella larvae (n = 10). Virulence was determined by
larvae death and melanization. To determine the effect of bacterial co-culture on
virulence, larvae were initially infected with P. aeruginosa and 24 hours later with
Streptococcus sp.
Results: A pyorubin producing P. aeruginosa isolate displayed greatest virulence
with inocula of 108 to 106 CFU/ml resulting in 0% survival at 21 h. S. parasanguinis
displayed greater virulence than other Streptococcus sp. At 72 h, the survival rate
of larvae sequentially inoculated with P. aeruginosa (104 CFU/ml) and S. oralis
(107 CFU/ml) was 60% compared to 80% for larvae infected with P. aeruginosa
only. All larvae inoculated with only S. oralis (107 CFU/ml) survived. Inoculation
of larvae with Prevotella resulted in melanization of larvae but not death.
Conclusion: The virulence of P. aeruginosa is dependent on the phenotype. Larvae
which have been infected with both P. aeruginosa and Streptococcus sp. display
a reduction in survival suggesting an interaction between bacteria which increases
virulence.
Funded by Society for Applied Microbiology and Nufﬁeld Foundation vacation
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Objectives: Small colony variants (SCVs) of P. aeruginosa are often isolated in CF
that show changes favouring chronic colonization. In a murine model of chronic
pulmonary colonization with P. aeruginosa, a phenotypically stable SCV arose
during the course of infection. We characterized the genomic and transcriptomic
characteristics of the SCV compared to the parent strain, to establish the mechanism
behind the switch to the SCV phenotype.
Methods: The SCV arose within 3 days of colonization. Genomic and transcrip-
tomic analysis was performed by Illumina sequencing.
Results: The SCV showed a highly stable phenotype on repeated subculture.
Analysis showed typical SCV colony morphology with markedly increased bioﬁlm
production. Pulsed ﬁeld gel electrophoresis showed no difference between parent
NH strain and the SCV. DNA sequencing revealed few consistent changes between
the parent and SCV other than a single nucleotide mutation within the algD gene.
Initial RNA-seq transcriptomic analysis suggests differential expression of over
400 genes, almost all upregulated in the SCV, and many involved in adaptations
to adverse environments. These included homologues of the Psl locus involved in
bioﬁlm formation, a hyperosmolar induced protein, and EF-Tu, a bacterial ligand
for the platelet activating receptor, important in epithelial adhesion.
Conclusion: The heritable change in the SCV responsible for its phenotype
remains obscure but may involve epigenetic change which we are investigating
with PacBio™ sequencing. The observed upregulated genes give insight into the
adaptations required for bacterial survival within the CF lung that could be novel
therapeutic targets.
